STOCK TITAN

Hercules Capital Inc SEC Filings

HCXY NYSE

Welcome to our dedicated page for Hercules Capital SEC filings (Ticker: HCXY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Hercules Capital filings document a specialty finance issuer with NYSE-listed common stock and 6.25% Notes due 2033 trading under HCXY. The company’s Form 8-K reports cover operating results, financial condition, net asset value estimates, stockholder distributions, executive appointments and material financing agreements, including supplemental indentures for unsecured notes.

Proxy materials describe board matters, executive compensation and annual meeting proposals. The filing record also identifies the company’s capital structure, registered securities, distribution practices, leverage and liquidity disclosures, and the role of Hercules Adviser LLC as a registered investment adviser managing external Adviser Funds.

Rhea-AI Summary

Hercules Capital, Inc. Chief Financial Officer Seth H. Meyer filed an amended insider trading report to correct an administrative error in the number of common shares previously reported as purchased. The amendment confirms his open-market purchase of 14,000 shares at an average price of $14.33 on February 27, 2026, and states that his total beneficial ownership of 448,553 shares was already correctly reported in the original Form 4.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Hercules Capital, Inc. director Nikos Theodosopoulos reported an open-market purchase of common stock. He bought 2,600 shares at a price of $14.21 per share. Following this transaction, his directly held stake increased to 21,523 shares of Hercules Capital common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Hercules Capital, Inc. director Robert P. Badavas reported an indirect open-market purchase of 5,000 shares of common stock at $14.27 per share through the Robert P. Badavas Trust of 2007. Following this transaction, the trust holds 122,073 shares, and Badavas also reports 1,412 shares held directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Hercules Capital, Inc. Chief Legal Officer & CCO Kiersten Zaza Botelho bought 1,300 shares of common stock in an open-market purchase at an average price of $14.21 per share. After this transaction, she directly owns 93,336 Hercules Capital common shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Hercules Capital director Thomas J. Fallon reported an open-market purchase of 20,000 shares of common stock at an average price of $14.20 per share. The filing notes the shares were bought at prices between $14.16 and $14.22 and are held indirectly by the Fallon Family Revocable Trust. Following this transaction, the trust holds 150,369 shares, and Fallon also reports 5,779 shares held directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Hercules Capital, Inc. Chief Financial Officer Seth H. Meyer reported an open-market purchase of 7,000 shares of common stock. The shares were bought at an average price of $14.33 per share, with trade prices ranging between $14.30 and $14.35. Following this transaction, Meyer directly owns 448,553 shares of Hercules Capital common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Hercules Capital, Inc. Chief Executive Officer Scott Bluestein reported an open-market purchase of 7,000 shares of common stock. The average purchase price was $14.35 per share, with trades executed between $14.30 and $14.36. Following this transaction, he directly owns 2,516,379 common shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Hercules Capital director Wade Loo, through the Loo Revocable Trust, bought 3,300 shares of common stock in an open-market purchase at $14.98 per share. After this indirect purchase, the trust held 32,767 shares, and Loo also held 6,630 shares directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Hercules Capital, Inc. director Robert P. Badavas reported an open‑market purchase of 5,000 shares of common stock on behalf of the Robert P. Badavas Trust of 2007. The shares were bought at an average purchase price with trades executed between $15.01 and $15.02 per share.

After this transaction, the trust held a total of 117,073 Hercules Capital shares indirectly attributed to Badavas, while he also held 1,412 shares directly. This filing reflects a net increase in his overall reported ownership position in the company.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Hercules Capital, Inc. director Thomas J. Fallon reported an indirect open-market purchase of 10,000 shares of common stock at $14.98 per share on February 24, 2026. The shares are held by the Fallon Family Revocable Trust.

After this transaction, the trust holds a total of 130,369 common shares, and Fallon also reports 5,779 common shares held directly. The filing highlights increased indirect ownership through the family trust structure.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Hercules Capital (HCXY) SEC filings are available on StockTitan?

StockTitan tracks 63 SEC filings for Hercules Capital (HCXY), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Hercules Capital (HCXY)?

The most recent SEC filing for Hercules Capital (HCXY) was filed on March 2, 2026.